Abstract
Generalized anxiety disorder is described as an excessive and disproportionate anxiety and worry about minor matters in daily living, which are accompanied with wide spectrum of somatic symptoms. This review is focused primary on current guidelines and news in pharmacological treatment.
Further it is focused on psychotherapy options and possibilities of clinical application of rTMS, or ketamin. After decades of relative stagnation the field of clinical testing is opening also for group of anxiety disorders.
In our review we also overview current ongoing clinical trials, which show the possibilities of treatment generalised anxiety disorder in the future.